Sonova Holding (OTCMKTS:SONVY) Receives Consensus Rating of “Reduce” from Analysts

Shares of Sonova Holding (OTCMKTS:SONVY) have been assigned an average rating of “Reduce” from the eight analysts that are covering the stock, MarketBeat reports. Four analysts have rated the stock with a sell recommendation and four have issued a hold recommendation on the company.

SONVY has been the subject of a number of research reports. BNP Paribas cut shares of Sonova from a “strong-buy” rating to a “strong sell” rating in a report on Wednesday, June 11th. Kepler Capital Markets raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research report on Friday, June 6th. HSBC cut Sonova from a “buy” rating to a “hold” rating in a report on Wednesday, May 21st. Barclays lowered Sonova from a “hold” rating to a “strong sell” rating in a report on Friday, June 20th. Finally, Hsbc Global Res downgraded Sonova from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 21st.

Sonova Trading Down 0.7%

OTCMKTS SONVY opened at $57.22 on Friday. The company has a 50-day moving average price of $61.75 and a 200-day moving average price of $62.56. Sonova has a 52 week low of $52.83 and a 52 week high of $77.56. The company has a quick ratio of 0.96, a current ratio of 1.27 and a debt-to-equity ratio of 0.45.

Sonova Increases Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, July 2nd. Stockholders of record on Tuesday, June 17th were given a dividend of $0.6243 per share. This represents a dividend yield of 0.99%. This is an increase from Sonova’s previous dividend of $0.57. The ex-dividend date of this dividend was Monday, June 16th.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.